Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i> -NT in Patients with Advanced Solid Tumors

Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, Ecaterina E. Dumbrava, David S. Hong, Daniel D. Karp, Aung Naing, Jordi Rodon, Apostolia M. Tsimberidou, Ravi Murthy, Rahul A. Sheth, Rodabe N. Amaria, Anthony P. Conley, Senthil Damodaran, Kanwal P.S. Raghav, Nicoleta Carapanceanu, Mahendra Pal Singh, Valentin Carapanceanu, Abdulmohammad Pezeshki, Alexey A. Leontovich, Brent L. Kreider, David Tung, Mary Varterasian, Khashayarsha Khazaie, Sarina A. Piha-Paul

Open source

DOI
10.1158/1078-0432.ccr-24-3952
Published
2025-07-11
Container
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-3952,
  title = {Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of
                    <i>Clostridium novyi</i>
                    -NT in Patients with Advanced Solid Tumors},
  author = {Blessie Elizabeth Nelson and Filip Janku and Siqing Fu and Ecaterina E. Dumbrava and David S. Hong and Daniel D. Karp and Aung Naing and Jordi Rodon and Apostolia M. Tsimberidou and Ravi Murthy and Rahul A. Sheth and Rodabe N. Amaria and Anthony P. Conley and Senthil Damodaran and Kanwal P.S. Raghav and Nicoleta Carapanceanu and Mahendra Pal Singh and Valentin Carapanceanu and Abdulmohammad Pezeshki and Alexey A. Leontovich and Brent L. Kreider and David Tung and Mary Varterasian and Khashayarsha Khazaie and Sarina A. Piha-Paul},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-3952},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-3952}
}

RIS

TY  - JOUR
TI  - Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of
                    <i>Clostridium novyi</i>
                    -NT in Patients with Advanced Solid Tumors
AU  - Blessie Elizabeth Nelson
AU  - Filip Janku
AU  - Siqing Fu
AU  - Ecaterina E. Dumbrava
AU  - David S. Hong
AU  - Daniel D. Karp
AU  - Aung Naing
AU  - Jordi Rodon
AU  - Apostolia M. Tsimberidou
AU  - Ravi Murthy
AU  - Rahul A. Sheth
AU  - Rodabe N. Amaria
AU  - Anthony P. Conley
AU  - Senthil Damodaran
AU  - Kanwal P.S. Raghav
AU  - Nicoleta Carapanceanu
AU  - Mahendra Pal Singh
AU  - Valentin Carapanceanu
AU  - Abdulmohammad Pezeshki
AU  - Alexey A. Leontovich
AU  - Brent L. Kreider
AU  - David Tung
AU  - Mary Varterasian
AU  - Khashayarsha Khazaie
AU  - Sarina A. Piha-Paul
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-3952
UR  - https://doi.org/10.1158/1078-0432.ccr-24-3952
ER  - 

APA

Nelson, B. E., Janku, F., Fu, S., Dumbrava, E. E., Hong, D. S., Karp, D. D., Naing, A., Rodon, J., Tsimberidou, A. M., Murthy, R., Sheth, R. A., Amaria, R. N., Conley, A. P., Damodaran, S., Raghav, K. P., Carapanceanu, N., Singh, M. P., Carapanceanu, V., Pezeshki, A., Leontovich, A. A., Kreider, B. L., Tung, D., Varterasian, M., Khazaie, K., & Piha-Paul, S. A. (2025). Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of <i>Clostridium novyi</i> -NT in Patients with Advanced Solid Tumors. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-3952

Source records